Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychooncology. 2013 Dec;22(12):2807-14. doi: 10.1002/pon.3352. Epub 2013 Jul 29.

Barriers and facilitators to effective communication experienced by patients with malignant lymphoma at all stages after diagnosis.

Author information

  • 1NIVEL, Utrecht, The Netherlands.

Abstract

OBJECTIVE:

This study aims to gain insight into patient-perceived communication barriers and facilitators at different stages after the diagnosis of malignant lymphoma. We have detected patterns to explain when these factors influence communication predominantly.

METHOD:

A qualitative approach was applied, derived from the context mapping framework. A total of 28 patients completed a set of assignments about their experiences with provider-patient communication during medical consultations. Subsequently, these patients and nine companions shared their experiences during a semistructured (group) interview, which was recorded on audiotape. The audiotapes and assignments were analysed with MAXQDA software.

RESULTS:

From the patients' viewpoint, communicating effectively appears to depend on their own attributes (e.g. emotions), the health care professionals' attributes (e.g. attitude) and external factors (e.g. time pressure). Three patient communication states were identified: (i) overwhelmed, passive; (ii) pro-active, self-motivated; and (iii) proficient, empowered. Patients seem to behave differently in the three communication states.

CONCLUSIONS:

This study lists patient-perceived communication barriers and facilitators and identifies three different communication states, which indicate when certain barriers and facilitators are encountered.

PRACTICAL IMPLICATIONS:

These findings may support health care professionals to tailor the provision of support and information and remove communication barriers accordingly. Additionally, they provide input for interventions to support patients in effective communication.

KEYWORDS:

cancer care; effective communication; malignant lymphoma; oncology; patient participation; patient-provider communication

PMID:
23897828
DOI:
10.1002/pon.3352
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center